Gun laws, nicotine pouches, GLP-1s for addiction

Theresa Gaffney, the lead Morning Rounds writer, provides insightful reporting on health care, new research, and public policy, with a keen focus on mental health, gender-affirming care, and LGBTQ+ patient communities. You can connect with Theresa on Signal at theresagaff.97.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

And just like that, the newsletter is back. I hope you had a restful weekend.

How one elite rehab center is ‘obliterating’ all kinds of cravings with GLP-1s

Ever since blockbuster weight loss medications made their mark, GLP-1s have emerged as more than just a tool for shedding pounds. They hold the potential to revolutionize our understanding of desire, with early data suggesting a promising role in treating addiction. However, only a few clinical trials are currently in progress, with some unlikely to release results in the next two years.

This article is exclusive to STAT+ subscribers. To unlock this content and gain access to in-depth analysis, newsletters, premium events, and news alerts, subscribe to STAT+.

To read the rest of this story, subscribe to STAT+. Subscribe.

The information provided in this article offers valuable insights into the potential of GLP-1s in curbing cravings and addressing addiction. Stay informed with Morning Rounds for more updates on health care advancements.